// App-Quantinova.ai

: ABO Incompatible Listing in Early Childhood Results in Earlier Transplantation and Equal Post-Transplant Survival Despite Predominant Use in Sicker Patients

Researchers

Presenter

  • S. Urschel

Principal Investigators

  • M. McCoy

  • Z. Reinhardt

  • A. Dipchand

  • R.S. Cantor

  • D.A. Koehl

  • J.K. Kirklin

  • J.A. Ballweg

  • K.R. Kanter

  • W. Zuckerman

  • J. Sparks

  • W.F. Carlo

Medical Centers

  • The University of Louisville, Louisville, KY

  • Pediatric Nephrology, University of Alabama, Birmingham, AL

  • Columbia University Medical Center, New York, NY

  • Emory University School of Medicine, Atlanta, GA

  • University of Alberta, Edmonton, AB, Canada

  • Kirklin Institute for Research in Surgical Outcomes (KIRSO), Birmingham, AL

  • Hospital for Sick Children, Toronto, ON, Canada

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Pediatrics, Children's Hospital & Medical Center, Omaha, Omaha, NE

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved